A detailed history of Palo Alto Investors LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Palo Alto Investors LP holds 183,246 shares of UTHR stock, worth $66.1 Million. This represents 9.03% of its overall portfolio holdings.

Number of Shares
183,246
Previous 266,914 31.35%
Holding current value
$66.1 Million
Previous $85 Million 22.77%
% of portfolio
9.03%
Previous 10.76%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $26 Million - $30.4 Million
-83,668 Reduced 31.35%
183,246 $65.7 Million
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $192,879 - $269,588
-845 Reduced 0.32%
266,914 $85 Million
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $27 Million - $31.9 Million
-128,025 Reduced 32.35%
267,759 $61.5 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $38.7 Million - $46.3 Million
-180,123 Reduced 31.28%
395,784 $87 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $10.9 Million - $12.8 Million
-51,607 Reduced 8.22%
575,907 $130 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $447,279 - $579,957
2,100 Added 0.34%
627,514 $141 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $1.67 Million - $2.28 Million
-8,120 Reduced 1.28%
625,414 $174 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $258,597 - $310,584
-1,272 Reduced 0.2%
633,534 $133 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $3.19 Million - $4.41 Million
-18,273 Reduced 2.8%
634,806 $150 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $5.67 Million - $7.3 Million
-34,127 Reduced 4.97%
653,079 $117 Million
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $15.1 Million - $17.2 Million
-98,200 Reduced 12.5%
687,206 $115 Million
Q3 2020

Nov 16, 2020

BUY
$99.9 - $121.13 $1.9 Million - $2.3 Million
19,000 Added 2.48%
785,406 $79.3 Million
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $10.2 Million - $13.9 Million
-110,169 Reduced 12.57%
766,406 $92.7 Million
Q1 2020

May 15, 2020

SELL
$79.39 - $115.35 $32.7 Million - $47.6 Million
-412,327 Reduced 31.99%
876,575 $83.1 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $10.6 Million - $12.9 Million
-135,499 Reduced 9.51%
1,288,902 $114 Million
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $9.61 Million - $11 Million
-128,391 Reduced 8.27%
1,424,401 $114 Million
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $6.03 Million - $9.57 Million
-79,233 Reduced 4.85%
1,552,792 $121 Million
Q4 2018

Feb 14, 2019

BUY
$101.4 - $128.73 $688,607 - $874,205
6,791 Added 0.42%
1,632,025 $178 Million
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $263,267 - $307,960
2,603 Added 0.16%
1,625,234 $184 Million
Q1 2018

May 15, 2018

BUY
$107.21 - $151.94 $1.76 Million - $2.49 Million
16,381 Added 1.02%
1,622,631 $182 Million
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $18.5 Million - $23.7 Million
-156,400 Reduced 8.87%
1,606,250 $238 Million
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $202 Million - $241 Million
1,762,650
1,762,650 $207 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.